Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5,061,592
-
Total 13F shares
-
34,994
-
Share change
-
+34,994
-
Total reported value
-
$111,279
-
Price per share
-
$3.00
-
Number of holders
-
10
-
Value change
-
+$111,279
-
Number of buys
-
10
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q3 2024
As of 30 Sep 2024,
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,994 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, Nordwand Advisors, LLC, NATIONAL BANK OF CANADA /FI/, Federation des caisses Desjardins du Quebec, Rise Advisors, LLC, Jaffetilchin Investment Partners, LLC, Farther Finance Advisors, LLC, MORGAN STANLEY, TD Waterhouse Canada Inc., and OSAIC HOLDINGS, INC..
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.